X

Biotechnology

REGN Earnings: Regeneron Pharma Q3 revenue, adj. profit increase

Healthcare firm Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on Thursday reported an increase in adjusted earnings and revenues for the third…

AMGN Earnings: Highlights of Amgen’s Q3 2023 financial results

Biotechnology firm Amgen Inc. (NASDAQ: AMGN) on Tuesday reported higher revenues and adjusted earnings for the third quarter of 2023.…

BMY Earnings: Highlights of Bristol-Myers Squibb’s Q3 2023 results

Biotechnology company Bristol Myers Squibb (NYSE: BMY) Friday reported mixed results for the third quarter of 2023. The company also…

Earnings Summary: Highlights of Centene Corp’s Q3 2023 earnings report

Healthcare service provider Centene Corporation (NYSE: CNC) on Tuesday announced third-quarter 2023 earnings results, reporting a sharp increase in revenues…

Ocean Biomedical forms JV with Virion Therapeutics to find treatments for cancer and chronic infectious diseases

Biotechnology company Ocean Biomedical, Inc. (NASDAQ: OCEA) entered into a joint venture with Virion Therapeutics, LLC, to expedite and expand…

Ocean Biomedical’s cancer-targeting antibody candidate shows effective tumor reduction against a subset of NSCLC with EGFR mutations

Ocean Biomedical, Inc. (NASDAQ: OCEA), a biotechnology company that operates by partnering with leading researchers to accelerate new discoveries in…

Ocean Biomedical, Inc. (NASDAQ: OCEA) Research Summary

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a biotechnology company that operates by partnering with leading researchers to accelerate new discoveries…

Illumina, Inc Q2 2023 Earnings Conference Call Insights

Key highlights from Illumina, Inc (ILMN) Q2 2023 Earnings Concall Management Update: [00:07:42] ILMN now expects to ship more than…

Ocean Biomedical provides update on programs in malaria, fibrosis, and multiple cancers

Ocean Biomedical, Inc. (NASDAQ: OCEA) on Thursday provided an update on its broad range of programs in malaria, fibrosis, and…

Earnings Summary: Highlights of Illumina’s Q2 2023 results

Biotechnology company Illumina, Inc. (NASDAQ: ILMN) on Wednesday announced financial results for the second quarter of 2023. Second-quarter revenue came…

Earnings Summary: Highlights of Organon’s Q2 2023 results

Pharmaceutical company Organon & Co. (NYSE: OGN) has reported higher revenues and earnings for the second quarter of 2023. Second-quarter…

Charles River Laboratories International, Inc Q2 2023 Earnings Conference Call Insights

Key highlights from Charles River Laboratories International, Inc (CRL) Q2 2023 Earnings Concall Q&A Highlights: [00:34:34] Sandy Draper with Guggenheim…

Earnings Summary: Charles River Laboratories reports Q2 2023 results

Pharma company Charles River Laboratories International, Inc. (NYSE: CRL) on Wednesday reported financial results for the second quarter of 2023.…

Ocean Biomedical’s share price target averages $18.21 amid continued progress in research programs

Ocean Biomedical, Inc. (NASDAQ: OCEA) on Wednesday shared collective analyst research coverage from three firms, with current Buy recommendations and…

Earnings Summary: Bio-Techne Corp (TECH) reports higher Q4 profit, revenue

Biotechnology company Bio-Techne Corporation (NASDAQ: TECH) on Tuesday announced financial results for the fourth quarter of 2023, reporting an increase…

Earnings Summary: Zoetis (ZTS) reports fiscal 2023 Q2 results

Animal healthcare company Zoetis Inc. (NYSE: ZTS) announced operating results for the second quarter, reporting higher adjusted profit and sales.…

AMGN Earnings: Everything you need to know about Amgen’s Q2 results

Amgen Inc. (NASDAQ: AMGN) on Friday reported higher revenues and adjusted earnings for the second quarter of 2023. The biotechnology…

CVS Health Corporation Q2 2023 Earnings Conference Call Insights

Key highlights from CVS Health Corporation (CVS) Q2 2023 Earnings Concall Management Update: [00:14:22] CVS said its restructuring efforts are…

CVS Health Q2 2023 earnings drop despite higher revenues

Healthcare conglomerate CVS Health Corporation (NYSE: CVS) announced second-quarter 2023 results, reporting lower earnings despite an increase in revenues. June…

Ocean Biomedical shares details of its successful lung cancer program on World Lung Cancer Day

Biopharmaceutical company Ocean Biomedical, Inc. (NASDAQ: OCEA) provided details of its multi-pronged lung cancer program built on novel immunotherapy discoveries…

BMY Earnings: A snapshot of Bristol-Myers Squibb’s Q2 2023 results

Biotechnology company Bristol Myers Squibb (NYSE: BMY) on Thursday said its second-quarter adjusted earnings decreased year-over-year, hurt by a fall…